Jim Simons Brooklyn Immuno Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $0.71 $56,079 - $173,116	243,826 Added 20.05%	1,459,626 $360,000
Q2 2022 Aug 12, 2022	BUY	$0.48 - $2.03 $304,035 - $1.29 Million	633,408 Added 108.76%	1,215,800 $629,000
Q1 2022 May 13, 2022	BUY	$1.76 - $4.84 $501,042 - $1.38 Million	284,683 Added 95.62%	582,392 $1.19 Million
Q4 2021 Feb 11, 2022	BUY	$4.17 - $9.79 $1.24 Million - $2.91 Million	297,709 New	297,709 $1.24 Million
Q2 2021 Aug 13, 2021	SELL	$3.75 - $78.5 $74,437 - $1.56 Million	-19,850 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$3.72 - $12.76 $73,842 - $253,286	19,850 New	19,850 $74,000

1.21M

Ticker BTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,825,700
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.